Please login to the form below
5
Revenue 2017Avastin
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Avastin was produced by Roche.
Roche reports positive phase 3 data for Tecentriq combination in liver cancer
Safety for both Tecentriq and Avastin was reportedly consistent with the known safety profile of each medicine and with the underlying disease. ... With Tecentriq plus Avastin already a standard of care in unresectable HCC, we are pleased with the
Paris Court of Appeal overturns Novartis and Roche’s €444m anti-competitiveness fine
been ‘measured in tone’ in their comments about Avastin’s use in AMD. ... The court also ruled that Roche’s refusal to supply samples of Avastin for a comparator clinical trial could not have had an anti-competitive effect.
Genentech reports positive phase 3 data for its Tecentriq combination in liver cancer
Tecentriq in combination with Avastin significantly improved recurrence-free survival. Genentech – a member of the Roche group – has announced that its phase 3 study of Tecentriq (atezolizumab) combination mets its primary ... Safety for both
FDA approves ImmunoGen’s Elahere for platinum-resistant ovarian cancer
of FRα and who had been treated with one to three prior systemic treatment regimens – at least one of which included Avastin (bevacizumab).
EC approves Celltrion Healthcare’s Vegzelma for multiple cancer types
The biosimilar to Genentech's Avastin was found to be highly similar to the reference product. ... Vegzelma is a recombinant humanised monoclonal antibody treatment biosimilar to Genentech's Avastin (bevacizumab), which is approved in the EU.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
- Presenting Outstanding Outcomes from HCP Education in Multiple Myeloma at IMS in Athens
No results were found
PMHub
Research Partnership
Research Partnership, an Inizio Advisory Company, is a world-leading custom and syndicated global insights partner for health and life science...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
